AB Science: CAB Reviews and VetMed Resources Publish a Comprehensive Review on the Clinical Development of Masitinib in Veterinary Medicine

Published: Jun 29, 2011

PARIS--(BUSINESS WIRE)--AB Science SA (Paris:AB)(NYSE-Euronext, FR0010557264, AB), a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors, announces the publication of a wide-ranging review article entitled ‘Masitinib – a targeted therapy with applications in veterinary oncology and inflammatory diseases’ in the peer-reviewed journal CAB Reviews and on the veterinary continuing education website VetMed Resources.

Back to news